GLPwatch
Mounjaro for Gastroparesis
tirzepatide · Investigational / off-label
Last updated 2026-05-28 15:46 UTCMounjaro (tirzepatide) is not FDA-approved for gastroparesis, and its use for this condition is off-label/investigational. Research suggests a possible link between tirzepatide and delayed gastric emptying, which may pose risks during procedures like upper endoscopy.
AI summary of the sources below.
| Drug | Mounjaro (tirzepatide) |
|---|---|
| Condition | Gastroparesis |
| Approval status | Investigational / off-label |
| Research papers | 2 |
Mounjaro is not FDA-approved for gastroparesis; the research below reflects investigational or off-label study only.